BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

719 related articles for article (PubMed ID: 15934092)

  • 41. Prevalence, predictors and outcome of vascular damage in systemic lupus erythematosus.
    Becker-Merok A; Nossent J
    Lupus; 2009 May; 18(6):508-15. PubMed ID: 19395452
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The rate and pattern of organ damage in late onset systemic lupus erythematosus.
    Maddison P; Farewell V; Isenberg D; Aranow C; Bae SC; Barr S; Buyon J; Fortin P; Ginzler E; Gladman D; Hanly J; Manzi S; Nived O; Petri M; Ramsey-Goldman R; Sturfelt G;
    J Rheumatol; 2002 May; 29(5):913-7. PubMed ID: 12022349
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.
    Von Feldt JM; Scalzi LV; Cucchiara AJ; Morthala S; Kealey C; Flagg SD; Genin A; Van Dyke AL; Nackos E; Chander A; Gehrie E; Cron RQ; Whitehead AS
    Arthritis Rheum; 2006 Jul; 54(7):2220-7. PubMed ID: 16802358
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus.
    Mok CC; Lau CS; Wong RW
    J Rheumatol; 2001 Apr; 28(4):766-71. PubMed ID: 11327248
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictors of damage progression in Portuguese patients with systemic lupus erythematosus.
    Santos MJ; Vinagre F; Nero P; Barcelos F; Barcelos A; Rodrigues AM; de Matos AA; Silva C; Miranda L; Capela S; Marques A; Branco J; da Silva JC
    Ann N Y Acad Sci; 2009 Sep; 1173():822-8. PubMed ID: 19758234
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Young age at onset, renal involvement, and arterial hypertension are of adverse prognostic significance in juvenile systemic lupus erythematosus.
    Marini R; Costallat LT
    Rev Rhum Engl Ed; 1999 Jun; 66(6):303-9. PubMed ID: 10418057
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women.
    Costenbader KH; Feskanich D; Stampfer MJ; Karlson EW
    Arthritis Rheum; 2007 Apr; 56(4):1251-62. PubMed ID: 17393454
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Characterization of a Portuguese population with systemic lupus erytematosus].
    Santos MJ; Capela S; Figueira R; Nero P; Matos AA; Silva C; Miranda L; Barcelos A; Marques A; Teixeira A; Branco J; da Silva JC; de Queiroz MV
    Acta Reumatol Port; 2007; 32(2):153-61. PubMed ID: 17576395
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Summarizing disease features over time: II. Variability measures of SLEDAI-2K.
    Ibañez D; Gladman D; Urowitz M
    J Rheumatol; 2007 Feb; 34(2):336-40. PubMed ID: 17183620
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Health-related quality of life in portuguese SLE patients: an outcome measure independent of disease activity and cumulative damage.
    Duarte C; Abreu P; Couto M; Vaz C; Malcata A; Inês L
    Acta Reumatol Port; 2010; 35(1):30-5. PubMed ID: 20518146
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA L II): relationship between vascular events and the use of hormone replacement therapy in postmenopausal women.
    Fernández M; Calvo-Alén J; Bertoli AM; Bastian HM; Fessler BJ; McGwin G; Reveille JD; Vilá LM; Alarcón GS
    J Clin Rheumatol; 2007 Oct; 13(5):261-5. PubMed ID: 17921793
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual.
    Alarcón GS; McGwin G; Bartolucci AA; Roseman J; Lisse J; Fessler BJ; Bastian HM; Friedman AW; Reveille JD;
    Arthritis Rheum; 2001 Dec; 44(12):2797-806. PubMed ID: 11762940
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical, immunogenetic and outcome features of Hispanic systemic lupus erythematosus patients of different ethnic ancestry.
    Calvo-Alén J; Reveille JD; Rodríguez-Valverde V; McGwin G; Baethge BA; Friedman AW; Alarcón GS
    Lupus; 2003; 12(5):377-85. PubMed ID: 12765301
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SLICC/ACR Damage Index in Afro-Caribbean patients with systemic lupus erythematosus: changes in and relationship to disease activity, corticosteroid therapy, and prognosis.
    Nossent JC
    J Rheumatol; 1998 Apr; 25(4):654-9. PubMed ID: 9558165
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antimalarial treatment may have a time-dependent effect on lupus survival: data from a multinational Latin American inception cohort.
    Shinjo SK; Bonfá E; Wojdyla D; Borba EF; Ramirez LA; Scherbarth HR; Brenol JC; Chacón-Diaz R; Neira OJ; Berbotto GA; De La Torre IG; Acevedo-Vázquez EM; Massardo L; Barile-Fabris LA; Caeiro F; Silveira LH; Sato EI; Buliubasich S; Alarcón GS; Pons-Estel BA;
    Arthritis Rheum; 2010 Mar; 62(3):855-62. PubMed ID: 20131238
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Disease activity, damage and survival in Mexican patients with acute severe systemic lupus erythematosus.
    Zonana-Nacach A; Yañez P; Jiménez-Balderas FJ; Camargo-Coronel A
    Lupus; 2007; 16(12):997-1000. PubMed ID: 18042596
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity.
    American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Response Criteria
    Arthritis Rheum; 2004 Nov; 50(11):3418-26. PubMed ID: 15529383
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Participatory patient-physician communication and morbidity in patients with systemic lupus erythematosus.
    Ward MM; Sundaramurthy S; Lotstein D; Bush TM; Neuwelt CM; Street RL
    Arthritis Rheum; 2003 Dec; 49(6):810-8. PubMed ID: 14673968
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual.
    Vilá LM; Alarcón GS; McGwin G; Bastian HM; Fessler BJ; Reveille JD;
    J Rheumatol; 2005 Nov; 32(11):2150-5. PubMed ID: 16265693
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Health-related quality of life in juvenile-onset systemic lupus erythematosus and its relationship to disease activity and damage.
    Ruperto N; Buratti S; Duarte-Salazar C; Pistorio A; Reiff A; Bernstein B; Maldonado-Velázquez MR; Beristain-Manterola R; Maeno N; Takei S; Falcini F; Lepore L; Spencer CH; Pratsidou-Gertsi P; Martini A; Ravelli A
    Arthritis Rheum; 2004 Jun; 51(3):458-64. PubMed ID: 15188334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.